It has been demonstrated that miR-192-5p targets and negatively regulates macrophage inflammatory Peptide 2 Alpha (MIP2α) (CXCL2), a CXC chemokine that is produced by epithelial cells and is crucial for both human and mouse IBD. Here, CXCL2 is linked to inflammatory bowel disease.